IL33 and neoplasm: While the local growth of the metastatic A9 tumours lacking IL-33 expression at the site of injection was not significantly different between either the ILC2-deficient mice (transplanted with RORα−/− BM) or ILC2-producing mice (transplanted with WT BM), the numbers of A9 CTCs were dramatically increased in mice lacking ILC2s.